Related Experiment Video
Updated: May 18, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Acanthosis nigricans during treatment with aripiprazole
Peter Manu1, Zainab Al-Dhaher, Navin Dargani
11Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY 2Department of Psychiatry, Hofstra North Shore, Long Island Jewish School of Medicine, Hempstead, NY 3Department of Psychiatry, Albert Einstein College of Medicine, Bronx, NY 4Department of Psychiatry, Feinstein Institute for Medical Research, Manhasset, NY.
Abstract:
Aripiprazole is typically regarded as a metabolically sparing agent, in contrast to other second-generation antipsychotics, which are widely known to lead to weight gain and increase the cardiometabolic risk. We report for the first time the emergence of Acanthosis nigricans, a dermatological correlate of insulin resistance, during treatment with aripiprazole in an adolescent with a family history of diabetes mellitus.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Antipsychotic Drugs: Typical and Atypical Agents
Atherosclerosis IV: Nursing Management
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Type I Diabetes III: Clinical Manifestations